参考文献/References:
[1] Bootcov MR, Bauskin AR, Valenzuela SM,et al. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily[J].Proc Natl Acad Sci U S A, 1997,94(21):11514-11519.
[2] Karczewska-Kupczewska M, Kowalska I, Nikolajuk A,et al. Hyperinsulinemia acutely increases serum macrophage inhibitory cytokine-1 concentration in anorexia nervosa and obesity[J].Clin Endocrinol(Oxf), 2012,76(1):46-50. DOI: 10.1111/j.1365-2265.2011.04139.x.
[3] Dostálová I, Roubícek T, Bártlová M,et al. Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet[J].Eur J Endocrinol,2009,161(3):397-404. DOI: 10.1530/EJE-09-0417.
[4] Breit SN, Johnen H, Cook AD,et al. The TGF-β superfamily cytokine, MIC-1/GDF15: a pleotrophic cytokine with roles in inflammation, cancer and metabolism[J].Growth Factors, 2011,29(5):187-195. DOI: 10.3109/08977194.2011.607137.
[5] Bauskin AR, Jiang L, Luo XW,et al. The TGF-beta superfamily cytokine MIC-1/GDF15: secretory mechanisms facilitate creation of latent stromal stores[J].J Interferon Cytokine Res, 2010,30(6):389-397. DOI: 10.1089/jir.2009.0052.
[6] Ding Q, Mracek T, Gonzalez-Muniesa P,et al. Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytes[J].Endocrinology, 2009,150(4):1688-1696. DOI: 10.1210/en.2008-0952.
[7] Wang X, Chrysovergis K, Kosak J,et al. hNAG-1 increases lifespan by regulating energy metabolism and insulin/IGF-1/mTOR signaling[J].Aging(Albany NY), 2014,6(8):690-704. DOI:10.18632/aging.100687.
[8] Chrysovergis K, Wang X, Kosak J, et al. NAG-1/GDF-15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism[J].Int J Obes(Lond), 2014,38(12):1555-1564. DOI: 10.1038/ijo.2014.27.
[9] Johnen H, Lin S, Kuffner T,et al. Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1[J].Nat Med, 2007,13(11):1333-1340.DOI:10.1038/nm1677.
[10] Tsai VW, Macia L, Johnen H,et al. TGF-b superfamily cytokine MIC-1/GDF15 is a physiological appetite and body weight regulator[J].PLoS One, 2013,8(2):e55174. DOI: 10.1371/journal.pone.0055174.
[11] Macia L, Tsai VW, Nguyen AD,et al. Macrophage inhibitory cytokine 1(MIC-1/GDF15)decreases food intake, body weight andimproves glucose tolerance in mice on normal & obesogenic diets[J].PLoS One, 2012,7(4):e34868. DOI: 10.1371/journal.pone.0034868.
[12] Dostálová I, Kaválková P, Papezová H,et al. Association of macrophage inhibitory cytokine-1 with nutritional status, body composition andbone mineral density in patients with anorexia nervosa: the influence of partialrealimentation[J].Nutr Metab(Lond), 2010,7:34. DOI: 10.1186/1743-7075-7-34.
[13] Bartke A, Westbrook R. Metabolic characteristics of long-lived mice[J].Front Genet, 2012,3:288. DOI: 10.3389/fgene.2012.00288.
[14] Heeren J, Münzberg H. Novel aspects of brown adipose tissue biology[J].Endocrinol Metab Clin North Am, 2013,42(1):89-107. DOI: 10.1016/j.ecl.2012.11.004.
[15] Hong JH, Chung HK, Park HY,et al. GDF15 is a novel biomarker for impaired fasting glucose[J].Diabetes Metab J, 2014,38(6):472-479. DOI: 10.4093/dmj.2014.38.6.472.
[16] Lim S, Quon MJ, Koh KK. Modulation of adiponectin as a potential therapeutic strategy[J].Atherosclerosis, 2014,233(2):721-728. DOI 10.1016/j.atherosclerosis.2014.01.051.
[17] Kim JM, Kosak JP, Kim JK,et al. NAG-1/GDF15 transgenic mouse has less white adipose tissue and a reduced inflammatory response[J].Mediators Inflamm, 2013,2013:641851.DOI: 10.1155/2013/641851.
[18] Afanas’ev I. Signaling of reactive oxygen and nitrogen species in Diabetes mellitus[J].Oxid Med Cell Longev, 2010,3(6):361-373.
[19] van den Oever IA, Raterman HG, Nurmohamed MT,et al. Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus[J].Mediators Inflamm, 2010,2010:792393. DOI: 10.1155/2010/792393.
[20] Li J, Yang L, Qin W,et al. Adaptive induction of growth differentiation factor 15 attenuates endothelial cell apoptosis in response to high glucose stimulus[J].PLoS One, 2013,8(6):e65549. DOI: 10.1371/journal.pone.0065549.
相似文献/References:
[1]柯孟婷,孙家忠,李扬.3,5-二碘-L-甲状腺素对白色脂肪棕色化的作用[J].国际内分泌代谢杂志,2016,36(06):370.[doi:10.3760/cma.j.issn.1673-4157.2016.06.03]
Ke Mengting*,Sun Jiazhong,Li Yang..Effects of 3,5-diiodo-L-thyronine on browning of white adipose tissue[J].International Journal of Endocrinology and Metabolism,2016,36(06):370.[doi:10.3760/cma.j.issn.1673-4157.2016.06.03]
[2]高胜利,郭菲菲,徐珞,等.Nesfatin-1与肥胖的关系[J].国际内分泌代谢杂志,2016,36(06):384.[doi:10.3760/cma.j.issn.1673-4157.2016.06.06]
Gao Shengli,Guo Feifei,Xu Luo,et al.Relationship between nesfatin-1 and obesity[J].International Journal of Endocrinology and Metabolism,2016,36(06):384.[doi:10.3760/cma.j.issn.1673-4157.2016.06.06]
[3]刘玉洁,杨曦,马慧娟.MC4R在肥胖及糖代谢中的作用[J].国际内分泌代谢杂志,2016,36(06):391.[doi:10.3760/cma.j.issn.1673-4157.2016.06.08]
Liu Yujie*,YangXi,Ma Huijuan..Role of MC4R in obesity and glucose metabolism[J].International Journal of Endocrinology and Metabolism,2016,36(06):391.[doi:10.3760/cma.j.issn.1673-4157.2016.06.08]
[4]姚旻,赵爱源,李红涛,等.人体肥胖指数在评价2型糖尿病患者
肥胖中的应用价值[J].国际内分泌代谢杂志,2017,37(01):1.[doi:10.3760/cma.j.issn.1673-4157.2017.01.01]
Yao Min*,Zhao Aiyuan,Li Hongtao,et al.Body adiposity index and its value in obesity evaluation in patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2017,37(06):1.[doi:10.3760/cma.j.issn.1673-4157.2017.01.01]
[5]严克敏,朱惠娟,龚凤英.雷公藤红素:一种潜在的治疗肥胖症的新药物[J].国际内分泌代谢杂志,2017,37(01):32.[doi:10.3760/cma.j.issn.1673-4157.2017.01.09]
Yan Kemin,Zhu Huijuan,Gong Fengying..Celastrol:a potential and novel drug for obesity[J].International Journal of Endocrinology and Metabolism,2017,37(06):32.[doi:10.3760/cma.j.issn.1673-4157.2017.01.09]
[6]张群慧,陈明卫.miRNA与肥胖[J].国际内分泌代谢杂志,2017,37(01):35.[doi:10.3760/cma.j.issn.1673-4157.2017.01.10]
Zhang Qunhui,Chen Mingwei..microRNA and obesity[J].International Journal of Endocrinology and Metabolism,2017,37(06):35.[doi:10.3760/cma.j.issn.1673-4157.2017.01.10]
[7]梁绮君,胡晨鸣,黄容,等.山楂消脂胶囊对肥胖症患者炎性状态
及脂多糖水平的影响[J].国际内分泌代谢杂志,2017,37(04):236.
Liang Qijun,Hu Chenming,Huang Rong,et al.Effects of Shanzha xiaozhi capsule on inflammation and lipopolysaccharide level in obese patients[J].International Journal of Endocrinology and Metabolism,2017,37(06):236.
[8]马骥,都健.代谢手术影响骨代谢的机制研究[J].国际内分泌代谢杂志,2017,37(05):312.
Ma Ji,Du Jian..Mechanism study of effects of metabolic surgery on bone metabolism[J].International Journal of Endocrinology and Metabolism,2017,37(06):312.
[9]张灿 李宝新 郭淑芹 常文龙 王翯 姚琪 张云良.2型糖尿病合并肥胖患者血清Irisin
和SFRP5水平变化的研究[J].国际内分泌代谢杂志,2018,38(01):1.[doi:10.3760/cma.j.issn.1673-4157.2018.01.001]
Zhang Can*,Li Baoxin,Guo Shuqin,et al.The changes of serum Irisin and SFRP5 levels in obese patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2018,38(06):1.[doi:10.3760/cma.j.issn.1673-4157.2018.01.001]
[10]陈琦 袁莉.γ-氨基丁酸能信号系统与胰岛素抵抗[J].国际内分泌代谢杂志,2020,40(02):113.[doi:10.3760/cma.j.issn.1673-4157.2020.02.010]
Chen Qi,Yuan Li.Relationship between γ-aminobutyric acid signaling system and insulin resistance[J].International Journal of Endocrinology and Metabolism,2020,40(06):113.[doi:10.3760/cma.j.issn.1673-4157.2020.02.010]